Remdesivir for patients hospitalized with covid-19 severe pneumonia: a national cohort study (remdeco-19)

HIGHLIGHTS

• who: Jeremie Zerbit and colleagues from the Department of Pharmacy, Hospital at Home, University Hospitals of Paris, Paris, France have published the research work: Remdesivir for Patients Hospitalized with COVID-19 Severe Pneumonia: A National Cohort Study (Remdeco-19), in the Journal: (JOURNAL) of 15/06/2022
• what: To the efficacy results generally reported through a WHO scale dedicated to COVID-19, the study has the advantage of analyzing the SOFA, a score usually used in ICU and reflecting the clinical evolution of this category of critical patients.
• how: The authors conducted a . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.